Focused ultrasound is becoming increasingly preferred as a valuable non-invasive therapeutic technology in a variety of clinical areas including cardiology, endocrinology, oncology and women’s health. FUS demonstrates important and growing utility in a variety of application areas, using a range of modalities such as tissue destruction, drug delivery, neuro-stimulation and modulation, immunomodulation and stem cell honing. MRI has predominantly been used to guide FUS, however researchers today are developing ultrasound-guided FUS (USgFUS) applications because they are more flexible and less costly. Ultrasound is ideal not only for energy delivery, but also to identify, guide and target tissue in real time, as well as to monitor the treatment.
The Vantage system from Verasonics is used today at numerous institutions and companies worldwide for FUS research and product development. The Vantage 64LE, 128 and 256 systems are now available in high intensity focused ultrasound (HIFU) configurations, which enable both energy delivery and imaging using the same transmitters for flexible and comprehensive exploration with focused ultrasound.